Flualprazolam is a benzodiazepine that looks a lot like alprazolam (Xanax). Flualprazolam, unlike alprazolam, contains both chlorine and fluorine, not only chlorine. Flualprazolam is a brand-new research chemical that was only released in 2017. Because flualprazolam and alprazolam are so similar, many chemical research findings for the two substances are similar.
Sedation, anti-convulsion, muscle relaxation, amnesic outcomes, and peacefulness have all been linked to these findings. Flualprazolam’s effects are thought to be stronger than alprazolam’s, but not as strong as Clonazepam’s (Klonopin).
If you want to employ the flualprazolam research chemical, you need first learn about its legal status. Flualprazolam is currently unscheduled, therefore it is not prohibited in any nations. However, because it is so new, it may become prohibited in some countries in the not-too-distant future.
Flualprazolam, also known as C17H12N4ClF, is a white water-soluble powder.
The fluorine atom on the ortho position of the phenyl moiety distinguishes flualprazolam from the FDA-approved medicines alprazolam and triazolam. Triazolobenzodiazepines are all three substances. 8 Sedation, anxiolysis, forgetfulness, and possibly respiratory depression are all expected clinical effects of flualprazolam as a benzodiazepine. Alprazolam appears to be more hazardous than other benzodiazepines in overdose. 9 Although flualprazolam has not been investigated in detail, rat investigations of fluorinated diazepam analogues have shown potencies ranging from half to tenfold10; thus, the pharmacodynamic effects of fluorinated alprazolam cannot be predicted solely based on chemical structure.
The present widespread usage of novel psychoactive substances (NPS) leads in a large number of intoxications or deaths, making forensic investigation difficult. NPS with structures similar to banned compounds reach the illicit drug market quickly, and they are extensively distributed and used legally until they are scheduled. Benzodiazepines are often prescribed medicines that are also misused by drug users as a replacement or to alleviate the unpleasant effects of opiates or withdrawal symptoms.
In the last ten years, the number of unlawful benzodiazepine derivatives has grown, as chemical substitution of normal benzodiazepines or their metabolites has resulted in a considerable number of novel drugs with no clinical safety or approved clinical usage.
Recent flualprazolam-related incidents have alarmed regulatory agencies and international stakeholders, leading to suggestions that flualprazolam should be regulated internationally. Despite the little information on clinical consequences and pharmacologic properties available, urgent international control of flualprazolam is a critical measure for preventing its growing abuse worldwide.